Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Steve Cohen, SAC Capital Reveal 5.3% Stake in Intercept Pharmaceuticals

Steve Cohen‘s SAC Capital has just revealed a 5.3% stake in Intercept Pharmaceuticals Inc (NASDAQ:ICPT), a new filing with the SEC indicates. The filing, which is a 13G, indicates that Cohen is here for investment purposes only, and does not seek any activist changes.

Steven Cohen

Disclosure: none

Recommended Reading:

Karpus Management Ups Stakes in Zweig Total Return Fund and Western Asset Inflation Management Fund

This Week’s 6 Most Important Hedge Fund Moves

Alan Fournier, Pennant Capital Boost Stake in BioScrip

Loading...